Featured Research

from universities, journals, and other organizations

Unique protein interaction may drive most common genetic cause of Parkinson's disease

Date:
January 7, 2014
Source:
Gladstone Institutes
Summary:
Scientists have discovered how the interplay between two proteins in the brain fuels the degradation and death of the class of brain cells, or neurons, that leads to Parkinson's disease. These findings, which stand in stark contrast to conventional wisdom, lay much-needed groundwork for developing treatments that target the disease's elusive underlying mechanisms.

The consecutive images are of the same two neurons, imaged each day for five days. The top neuron does well throughout the five days. However the lower neuron begins to degenerate on the third day. And by the fourth day, it is gone. By longitudinally tracking neurons the Gladstone research team has much greater power at picking up differences in neurons that had mutant LRRK2, and those that did not.
Credit: Gaia Skibinski

The most devastating aspect of Parkinson's disease may not be its debilitating symptoms, which rob its victims of their ability to control their own movement. It may not be the millions around the world and their families who suffer each day from the disease's harmful effects. Instead, it may in fact be that its root causes remain largely a mystery. But now, scientists at the Gladstone Institutes have discovered how the interplay between two proteins in the brain fuels the degradation and death of the class of brain cells, or neurons, that leads to Parkinson's. These findings, which stand in stark contrast to conventional wisdom, lay much-needed groundwork for developing treatments that target the disease's elusive underlying mechanisms.

Related Articles


In the latest issue of the Journal of Neuroscience, now available online, scientists in the laboratory of Gladstone Investigator Steve Finkbeiner, MD, PhD, harnessed the power of their one-of-a-kind robotic microscope to track the lifespan of individual neurons over time. The microscope has been used to study a variety of neurodegenerative diseases, and in this study, they focus their attention on LRRK2 -- the most common genetic cause of Parkinson's.

Scientists have long known that mutations in LRRK2 cause misfolded versions of the LRRK2 protein to accumulate in neurons. The prevailing hypothesis has been that misfolded LRRK2 boosts the activity of a type of enzyme called kinase, and that this heightened kinase activity is what drives cell death. Scientists have also looked to the fact that mutant LRRK2 tends to clump together into so-called inclusion bodies (IB's) as another contributor to the disease's progression.

"As a result, researchers have used the presence of IB's and heightened kinase activity as a proxy for measuring LRRK2's harmful effects, rather than measuring LRRK2 levels directly," explained Dr. Finkbeiner, who is the associate director of neurological research at Gladstone as well as a professor at the University of California, San Francisco, with which Gladstone is affiliated. "But we were unconvinced that these were the main drivers of cell death -- so we decided to take a closer look at what was happening inside the cell."

When studying neurodegenerative diseases such as Parkinson's, which are defined by the degradation and death of neurons, traditional tools usually only allow researchers to track neuronal death at the population level. But Dr. Finkbeiner's revolutionary microscope enables researchers to follow the lives of thousands of individual neurons -- offering the clearest view into which events during the lifetime of the cell play a role in its death.

The researchers generated neurons from two sources: from rats genetically modified to have mutant LRRK2, and human neurons derived from the skin cells of LRRK2-related Parkinson's patients. They then tracked these cells over time, monitoring the buildup of mutant LRRK2 and how that buildup led to cell death.

"Interestingly, we found that neither IB's nor kinase activity were the direct cause of cellular toxicity leading to neuronal death,," said Gladstone Staff Research Scientist Gaia Skibinski, PhD, the paper's lead author. "Instead, the underlying cause of cell death appeared to be tied directly to the accumulation of diffuse mutant LRRK2."

But as the research team peered even closer into the lives of these neurons, they found something intriguing: a unique interplay between mutant LRRK2 and alpha-synuclein, another protein that has long been associated with Parkinson's. Research has shown that Parkinson's patients with LRRK2 mutations often show an abnormal accumulation of alpha-synuclein. But until now, the exact nature of the relationship between these two proteins remained unclear.

"Importantly, we found that in both the rat and human cellular models, removing alpha-synuclein reduced cell death caused by mutant LRRK2," continued Dr. Skibinski. "When we looked closer, we found that loss of alpha-synuclein led to an immediate drop in LRRK2."

The team hypothesizes that, in patients with mutant LRRK2, the build-up of alpha-synuclein hinders the cell's ability to clear away LRRK2, leading to its accumulation. Over time, the buildup of LRRK2 becomes toxic to the cell, and the cell dies.

"The discovery of a synergistic relationship between two proteins long known to play a role in Parkinson's is a huge step towards developing drugs that attack the disease's underlying mechanisms," said Dr. Finkbeiner. "As we continue to unravel the precise functional relationship between alpha-synuclein and LRRK2, we are well on our way to halting the onslaught of Parkinson's on the brain."


Story Source:

The above story is based on materials provided by Gladstone Institutes. Note: Materials may be edited for content and length.


Journal Reference:

  1. G. Skibinski, K. Nakamura, M. R. Cookson, S. Finkbeiner. Mutant LRRK2 Toxicity in Neurons Depends on LRRK2 Levels and Synuclein But Not Kinase Activity or Inclusion Bodies. Journal of Neuroscience, 2014; 34 (2): 418 DOI: 10.1523/JNEUROSCI.2712-13.2014

Cite This Page:

Gladstone Institutes. "Unique protein interaction may drive most common genetic cause of Parkinson's disease." ScienceDaily. ScienceDaily, 7 January 2014. <www.sciencedaily.com/releases/2014/01/140107215351.htm>.
Gladstone Institutes. (2014, January 7). Unique protein interaction may drive most common genetic cause of Parkinson's disease. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2014/01/140107215351.htm
Gladstone Institutes. "Unique protein interaction may drive most common genetic cause of Parkinson's disease." ScienceDaily. www.sciencedaily.com/releases/2014/01/140107215351.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins